,outcome,arm 1,arm 2
0,intervention,"Capecitabine/docetaxel, docetaxel",
0,efficacy in time to disease progression ( TTP ),"14.5, 42 %, 6.1",11.5 months
0,"efficacy in time to disease progression ( TTP ), total study group",30 %,30 %
